Sarepta Therapeutics Inc (NASDAQ:SRPT)

Delayed Data
As of Apr 20
 +1.44 / +1.83%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 92.00, with a high estimate of 101.00 and a low estimate of 55.00. The median estimate represents a +15.01% increase from the last price of 79.99.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Buy stock in Sarepta Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 24.86%
Growthannually -35.65%


Growthquarterly 10.99%
Growthannually 96.64%
Key to the earnings and sales forecast charts.